https://news.medxy.ai/zh/rsv-infant-protection/Medxy AIzh2026-10-02T07:57:33-07:00高风险婴儿重症 RSV 的长效防护：两季随机试验揭示克雷索维单抗潜力 https://news.medxy.ai/ja/high-risk-infant-rsv-prevention/Medxy AIja2026-10-02T07:57:12-07:00高リスク乳児の重症RSVを長期に防ぐclesrovimab：2シーズン無作為化試験からの知見 https://news.medxy.ai/vi/clesrovimab-rsv-prevention-4/Medxy AIvi2026-10-02T07:56:49-07:00Clesrovimab: hy vọng mới trong phòng ngừa RSV nặng kéo dài ở trẻ sơ sinh nguy cơ cao https://news.medxy.ai/clesrovimab-for-prolonged-protection-against-severe-rsv-in-high-risk-infants-insights-from-a-two-season-randomized-trial/Medxy AIen2026-10-02T07:56:29-07:00Clesrovimab for Prolonged Protection Against Severe RSV in High-Risk Infants: Insights From a Two-Season Randomized Trial https://news.medxy.ai/zh/38-percent-silver-ammonium-fluoride/Medxy AIzh2026-10-02T07:55:46-07:0038%银氨氟化物：重度幼儿期龋的非侵入性治疗新突破 https://news.medxy.ai/ja/silver-diamine-fluoride/Medxy AIja2026-10-02T07:55:26-07:0038％silver diamine fluorideが切り開く新たな小児う蝕治療――米国の重度幼児う蝕に対する非侵襲的ブレークスルー https://news.medxy.ai/vi/silver-diamine-fluoride-2/Medxy AIvi2026-10-02T07:55:01-07:00Bạc diamine fluoride: Liệu pháp không xâm lấn đột phá cho sâu răng sớm ở trẻ em nặng tại Hoa Kỳ https://news.medxy.ai/silver-diamine-fluoride-a-breakthrough-noninvasive-therapy-for-severe-early-childhood-caries-in-us-children/Medxy AIen2026-10-02T07:54:37-07:00Silver Diamine Fluoride: A Breakthrough Noninvasive Therapy for Severe Early Childhood Caries in US Children https://news.medxy.ai/zh/pediatric-tbi-ct-use/Medxy AIzh2026-10-02T07:53:59-07:00儿童轻型创伤性脑损伤头部CT使用率居高不下：不同医院类型差异及其对临床实践的启示 https://news.medxy.ai/ja/79927-2/Medxy AIja2026-10-02T07:53:38-07:00小児の軽症外傷性脳損傷における頭部CT撮影率の高止まり https://news.medxy.ai/vi/79926-2/Medxy AIvi2026-10-02T07:53:11-07:00Tỷ lệ sử dụng chụp CT đối với chấn thương sọ não nhẹ ở trẻ em vẫn duy trì ở mức cao https://news.medxy.ai/persistent-high-rates-of-head-ct-in-pediatric-mild-traumatic-brain-injury-variability-among-hospital-types-and-implications-for-practice/Medxy AIen2026-10-02T07:52:48-07:00Persistent High Rates of Head CT in Pediatric Mild Traumatic Brain Injury: Variability Among Hospital Types and Implications for Practice https://news.medxy.ai/zh/type-1-diabetes-intervention/Medxy AIzh2026-10-02T07:52:05-07:00儿童1型糖尿病的行为干预：以家庭为中心的多组分策略优化血糖控制 https://news.medxy.ai/ja/pediatric-type1-diabetes/Medxy AIja2026-10-02T07:51:42-07:00小児1型糖尿病における行動介入：家族中心の多要素戦略で血糖管理を最適化する https://news.medxy.ai/vi/behavioral-intervention-type-1-diabetes/Medxy AIvi2026-10-02T07:51:19-07:00Can thiệp hành vi trong đái tháo đường type 1 ở trẻ em: tối ưu kiểm soát đường huyết bằng chiến lược đa thành phần, lấy gia đình làm trung tâm https://news.medxy.ai/behavioral-interventions-in-pediatric-type-1-diabetes-optimizing-glycemic-control-through-family-centered-multicomponent-strategies/Medxy AIen2026-10-02T07:50:54-07:00Behavioral Interventions in Pediatric Type 1 Diabetes: Optimizing Glycemic Control Through Family-Centered, Multicomponent Strategies https://news.medxy.ai/zh/79910-2/Medxy AIzh2026-10-02T07:50:10-07:00加强对拉美裔家庭婴幼儿读写能力的支持：一项验证短信与社区资源推介有效性的三组随机对照试验（RCT） https://news.medxy.ai/ja/latin-family-literacy/Medxy AIja2026-10-02T07:49:49-07:00ラテン系家族の乳幼児リテラシー支援を強化：テキストメッセージと地域資源紹介の有効性を検証した3群RCT https://news.medxy.ai/vi/promoting-childrens-reading/Medxy AIvi2026-10-02T07:49:20-07:00Tăng cường thúc đẩy đọc sách cho trẻ em trong các gia đình Latino: hiệu quả của nhắn tin văn bản và giới thiệu nguồn lực trong thử nghiệm ngẫu nhiên có đối chứng 3 nhánh https://news.medxy.ai/enhancing-pediatric-literacy-promotion-for-latino-families-efficacy-of-text-messaging-and-resource-referrals-in-a-3-arm-randomized-controlled-trial/Medxy AIen2026-10-02T07:48:55-07:00Enhancing Pediatric Literacy Promotion for Latino Families: Efficacy of Text Messaging and Resource Referrals in a 3-Arm Randomized Controlled Trial https://news.medxy.ai/zh/mri-ultrasound-arthritis/Medxy AIzh2026-10-02T07:48:06-07:00MRI 与超声可预测 anti-CCP 阳性无临床滑膜炎患者进展为炎性关节炎 https://news.medxy.ai/ja/inflammatory-arthritis-risk/Medxy AIja2026-10-02T07:47:42-07:00MRIと超音波で見抜く炎症性関節炎リスク：anti-CCP陽性・無症候性滑膜炎患者の予測因子 https://news.medxy.ai/vi/anti-ccp-arthritis-markers/Medxy AIvi2026-10-02T07:47:19-07:00Dấu ấn hình ảnh nào dự báo viêm khớp viêm ở người anti-CCP dương tính chưa có viêm hoạt dịch lâm sàng? https://news.medxy.ai/imaging-biomarkers-predicting-inflammatory-arthritis-in-anti-ccp-positive-patients-without-clinical-synovitis/Medxy AIen2026-10-02T07:46:56-07:00Imaging Biomarkers Predicting Inflammatory Arthritis in Anti-CCP Positive Patients Without Clinical Synovitis https://news.medxy.ai/zh/anca-vasculitis-relapse-risk/Medxy AIzh2026-10-02T07:46:16-07:00预测ANCA相关性血管炎两年复发风险：来自 PEXIVAS 试验的启示 https://news.medxy.ai/ja/anca-vasculitis-relapse-risk-3/Medxy AIja2026-10-02T07:45:54-07:00ANCA関連血管炎の2年再燃リスクを予測：PEXIVAS試験から見えた知見 https://news.medxy.ai/vi/anca-vasculitis-relapse-risk-2/Medxy AIvi2026-10-02T07:45:26-07:00Dự đoán nguy cơ tái phát trong 2 năm ở viêm mạch liên quan đến ANCA: Gợi ý từ thử nghiệm PEXIVAS https://news.medxy.ai/predicting-two-year-relapse-risk-in-anca-associated-vasculitis-insights-from-the-pexivas-trial/Medxy AIen2026-10-02T07:45:03-07:00Predicting Two-Year Relapse Risk in ANCA-Associated Vasculitis: Insights from the PEXIVAS Trial https://news.medxy.ai/zh/canakinumab-biomarkers/Medxy AIzh2026-10-02T07:44:24-07:00预测 canakinumab 减量成功的分子标志物：系统性幼年特发性关节炎的新线索 https://news.medxy.ai/ja/79884-2/Medxy AIja2026-10-02T07:44:03-07:00カナキヌマブ減量成功を予測する分子バイオマーカー https://news.medxy.ai/vi/canakinumab-dose-reduction/Medxy AIvi2026-10-02T07:43:39-07:00Các dấu ấn phân tử dự đoán khả năng giảm liều canakinumab thành công trong viêm khớp tự phát thiếu niên thể hệ thống https://news.medxy.ai/molecular-biomarkers-predicting-canakinumab-tapering-success-in-systemic-juvenile-idiopathic-arthritis/Medxy AIen2026-10-02T07:43:16-07:00Molecular Biomarkers Predicting Canakinumab Tapering Success in Systemic Juvenile Idiopathic Arthritis https://news.medxy.ai/zh/native-vs-transplant-bk-virus/Medxy AIzh2026-10-02T07:42:36-07:00原生肾与移植肾BK多瘤病毒肾病的比较：一项匹配队列研究中的临床与病理洞见 https://news.medxy.ai/ja/bk-polyomavirus-nephropathy/Medxy AIja2026-10-02T07:42:13-07:00自己腎と移植腎のBKポリオーマウイルス腎症を比較する：マッチドコホート研究からみた臨床・病理学的考察 https://news.medxy.ai/vi/79878-2/Medxy AIvi2026-10-02T07:41:49-07:00So sánh bệnh thận do virus BK Polyoma ở thận tự thân và thận ghép https://news.medxy.ai/comparative-insights-into-native-and-allograft-bk-polyomavirus-nephropathy-clinical-and-pathological-perspectives-from-a-matched-cohort-study/Medxy AIen2026-10-02T07:41:25-07:00Comparative Insights into Native and Allograft BK Polyomavirus Nephropathy: Clinical and Pathological Perspectives from a Matched Cohort Study https://news.medxy.ai/zh/optimize-kidney-transplant/Medxy AIzh2026-10-02T07:40:36-07:00优化肾移植结局：来自全国性双肾与单肾移植比较研究的启示 https://news.medxy.ai/ja/79866-2/Medxy AIja2026-10-02T07:40:14-07:00腎移植成績の最適化：両腎移植と単腎移植を比較した全国規模の研究からの示唆 https://news.medxy.ai/vi/kidney-transplant-optimization/Medxy AIvi2026-10-02T07:39:38-07:00Tối ưu hóa kết quả ghép thận: Góc nhìn từ một nghiên cứu quốc gia về ghép thận đôi so với ghép thận đơn https://news.medxy.ai/optimizing-kidney-transplant-outcomes-insights-from-a-national-study-on-dual-versus-single-kidney-transplantation/Medxy AIen2026-10-02T07:39:15-07:00Optimizing Kidney Transplant Outcomes: Insights from a National Study on Dual Versus Single Kidney Transplantation https://news.medxy.ai/zh/spain-organ-donation-trends/Medxy AIzh2026-10-02T07:38:23-07:00西班牙脑死亡器官捐献格局如何变化：神经重症医学与器官捐献趋势的全国概览 https://news.medxy.ai/ja/brain-death-organ-donation-spain/Medxy AIja2026-10-02T07:38:01-07:00スペインにおける脳死下臓器提供の変化：神経集中治療と臓器提供動向の全国的概観 https://news.medxy.ai/vi/spain-organ-donation/Medxy AIvi2026-10-02T07:37:36-07:00Tây Ban Nha trước sự dịch chuyển của hiến tạng sau chết não: Tổng quan quốc gia về hồi sức thần kinh và xu hướng hiến tạng https://news.medxy.ai/changing-brain-death-donation-dynamics-in-spain-a-national-overview-of-neurocritical-care-and-organ-donation-trends/Medxy AIen2026-10-02T07:37:14-07:00Changing Brain Death Donation Dynamics in Spain: A National Overview of Neurocritical Care and Organ Donation Trends https://news.medxy.ai/zh/medicaid-liver-transplant/Medxy AIzh2026-10-02T07:36:25-07:00Medicaid 扩大覆盖如何改善成人肝移植结局：长达十年的研究分析 https://news.medxy.ai/ja/medicaid-liver-transplant-2/Medxy AIja2026-10-02T07:36:08-07:00Medicaid拡大が成人肝移植転帰に与える影響：10年間の解析 https://news.medxy.ai/vi/medicaid-expansion-liver-transplant/Medxy AIvi2026-10-02T07:35:49-07:00Mở rộng Medicaid tác động thế nào đến kết cục ghép gan ở người lớn? Phân tích kéo dài 10 năm https://news.medxy.ai/impact-of-medicaid-expansion-on-adult-liver-transplant-outcomes-a-decade-long-analysis/Medxy AIen2026-10-02T07:35:29-07:00Impact of Medicaid Expansion on Adult Liver Transplant Outcomes: A Decade-Long Analysis https://news.medxy.ai/zh/lung-function-transplant/Medxy AIzh2026-10-02T07:34:43-07:00肝移植受者肺功能受损与呼吸困难：全国匹配队列研究带来的启示 https://news.medxy.ai/ja/lung-function-decline/Medxy AIja2026-10-02T07:34:23-07:00肝移植レシピエントにおける肺機能低下と呼吸困難：全国マッチドコホート研究からの示唆 https://news.medxy.ai/vi/lung-function-decline-2/Medxy AIvi2026-10-02T07:34:03-07:00Suy giảm chức năng phổi và khó thở ở người nhận ghép gan: bằng chứng từ một nghiên cứu đoàn hệ ghép cặp toàn quốc https://news.medxy.ai/impaired-pulmonary-function-and-dyspnea-in-liver-transplant-recipients-insights-from-a-nationwide-matched-cohort-study/Medxy AIen2026-10-02T07:33:43-07:00Impaired Pulmonary Function and Dyspnea in Liver Transplant Recipients: Insights from a Nationwide Matched Cohort Study https://news.medxy.ai/zh/liver-transplantation-advances/Medxy AIzh2026-10-02T07:32:59-07:00循环死亡后捐献肝移植新进展：常温机器灌注与区域灌注结局比较 https://news.medxy.ai/ja/liver-transplantation-comparison/Medxy AIja2026-10-02T07:32:35-07:00循環停止後臓器提供肝移植を前進させる：常温機械灌流と区域灌流の成績比較 https://news.medxy.ai/vi/liver-transplantation-comparison-2/Medxy AIvi2026-10-02T07:32:11-07:00Nâng tầm ghép gan từ người hiến sau ngừng tuần hoàn: so sánh kết cục tưới máu máy ở thân nhiệt bình thường và tưới máu vùng https://news.medxy.ai/advancing-donation-after-circulatory-death-liver-transplants-comparing-normothermic-machine-and-regional-perfusion-outcomes/Medxy AIen2026-10-02T07:31:48-07:00Advancing Donation After Circulatory Death Liver Transplants: Comparing Normothermic Machine and Regional Perfusion Outcomes https://news.medxy.ai/zh/dupilumab-eczema-kids/Medxy AIzh2026-10-02T07:31:04-07:00dupilumab治疗儿童中重度特应性皮炎：荷兰3年队列研究揭示长期疗效与安全性 https://news.medxy.ai/ja/dupilumab-child-eczema/Medxy AIja2026-10-02T07:30:42-07:00中等症から重症の小児アトピー性皮膚炎におけるDupilumabの長期有効性と安全性：オランダ3年間コホート研究からの知見 https://news.medxy.ai/vi/dupilumab-long-term-safety/Medxy AIvi2026-10-02T07:30:15-07:00Dupilumab duy trì hiệu quả và độ an toàn lâu dài ở trẻ em mắc viêm da cơ địa mức độ trung bình đến nặng: Kết quả từ nghiên cứu đoàn hệ 3 năm tại Hà Lan https://news.medxy.ai/sustained-efficacy-and-safety-of-dupilumab-in-children-with-moderate-to-severe-atopic-dermatitis-insights-from-a-3-year-dutch-cohort-study/Medxy AIen2026-10-02T07:29:55-07:00Sustained Efficacy and Safety of Dupilumab in Children with Moderate to Severe Atopic Dermatitis: Insights from a 3-Year Dutch Cohort Study https://news.medxy.ai/zh/arotitinib-cream-study/Medxy AIzh2026-10-02T07:29:01-07:001.5%芦可替尼乳膏治疗皮肤型扁平苔藓的疗效与安全性：随机临床试验综述 https://news.medxy.ai/ja/lansopitinib-skin-trial/Medxy AIja2026-10-02T07:28:41-07:00皮膚扁平苔癬に対するランソリチニブ外用クリームの有効性と安全性：ランダム化臨床試験レビュー https://news.medxy.ai/vi/ruxolitinib-cream-lichen-planus/Medxy AIvi2026-10-02T07:28:18-07:00Ruxolitinib cream trong lichen phẳng da: Hiệu quả, độ an toàn và ý nghĩa từ một thử nghiệm lâm sàng ngẫu nhiên https://news.medxy.ai/efficacy-and-safety-of-ruxolitinib-cream-in-patients-with-cutaneous-lichen-planus-a-randomized-clinical-trial-review/Medxy AIen2026-10-02T07:27:57-07:00Efficacy and Safety of Ruxolitinib Cream in Patients With Cutaneous Lichen Planus: A Randomized Clinical Trial Review https://news.medxy.ai/high-dose-oral-vitamin-d-for-management-of-chemotherapy-and-radiation-induced-skin-toxicity-a-multicenter-case-series/Medxy AIen2026-10-02T07:27:10-07:00High-Dose Oral Vitamin D for Management of Chemotherapy- and Radiation-Induced Skin Toxicity: A Multicenter Case Series https://news.medxy.ai/zh/rituximab-pemphigus-prediction/Medxy AIzh2026-10-02T07:26:27-07:00利妥昔单抗联合糖皮质激素治疗天疱疮患者短期结局的预测：来自中国多中心队列的启示 https://news.medxy.ai/ja/pemphigus-treatment-prediction/Medxy AIja2026-10-02T07:26:06-07:00リツキシマブ＋グルココルチコイド治療中の天疱瘡患者における短期転帰予測：中国多施設コホートからの知見 https://news.medxy.ai/vi/79791-2/Medxy AIvi2026-10-02T07:25:44-07:00Kết quả ngắn hạn của việc phối hợp rituximab và glucocorticoid ở bệnh nhân mắc bệnh pemphigus https://news.medxy.ai/predicting-short-term-outcomes-in-pemphigus-patients-treated-with-rituximab-and-glucocorticoids-insights-from-a-multicenter-chinese-cohort/Medxy AIen2026-10-02T07:25:26-07:00Predicting Short-Term Outcomes in Pemphigus Patients Treated with Rituximab and Glucocorticoids: Insights from a Multicenter Chinese Cohort https://news.medxy.ai/zh/dupilumab-atopic-dermatitis/Medxy AIzh2026-10-02T07:24:45-07:00儿童中重度特应性皮炎系统治疗新证据：PEDISTAD 登记研究显示 dupilumab 跨肤色疗效更佳 https://news.medxy.ai/ja/atopic-dermatitis-treatment/Medxy AIja2026-10-02T07:24:24-07:00PEDISTADレジストリが示した小児中等症から重症アトピー性皮膚炎に対する全身治療：皮膚色別の比較成績 https://news.medxy.ai/vi/atopic-dermatitis-treatment-2/Medxy AIvi2026-10-02T07:24:01-07:00Điều trị toàn thân viêm da cơ địa mức độ vừa đến nặng ở trẻ em: so sánh kết quả theo màu da từ cơ sở đăng ký PEDISTAD https://news.medxy.ai/systemic-therapies-for-pediatric-moderate-to-severe-atopic-dermatitis-comparative-outcomes-across-skin-colors-from-the-pedistad-registry/Medxy AIen2026-10-02T07:23:40-07:00Systemic Therapies for Pediatric Moderate-to-Severe Atopic Dermatitis: Comparative Outcomes Across Skin Colors from the PEDISTAD Registry https://news.medxy.ai/zh/plaque-psoriasis-flare/Medxy AIzh2026-10-02T07:22:58-07:00停用生物制剂后斑块型银屑病出现独特脓疱性发作：临床特征与危险因素 https://news.medxy.ai/ja/psoriasis-flare-after-treatment/Medxy AIja2026-10-02T07:22:38-07:00生物学的製剤中止後にみられる尋常性乾癬の特異的膿疱性増悪：臨床像と危険因子 https://news.medxy.ai/vi/psoriasis-pustular-flare/Medxy AIvi2026-10-02T07:22:16-07:00Bùng phát vảy nến mụn mủ đặc thù sau khi ngừng thuốc sinh học ở vảy nến mảng bám: đặc điểm lâm sàng và yếu tố nguy cơ https://news.medxy.ai/distinct-pustular-psoriasis-flares-after-biologic-withdrawal-in-plaque-psoriasis-clinical-features-and-risk-factors/Medxy AIen2026-10-02T07:21:53-07:00Distinct Pustular Psoriasis Flares After Biologic Withdrawal in Plaque Psoriasis: Clinical Features and Risk Factors https://news.medxy.ai/zh/breast-reconstruction-outcomes-2/Medxy AIzh2026-10-02T07:21:11-07:00两期乳房重建中聚二氧环己酮合成网片的短期结局：单中心比较研究的启示 https://news.medxy.ai/ja/polydioxanone-mesh-results/Medxy AIja2026-10-02T07:20:52-07:002期的乳房再建におけるポリジオキサノン合成メッシュの短期成績：単施設比較研究からの知見 https://news.medxy.ai/vi/polydioxanone-breast-reconstruction/Medxy AIvi2026-10-02T07:20:30-07:00Kết quả ngắn hạn của lưới tổng hợp polydioxanone trong tái tạo vú hai giai đoạn: Bằng chứng từ một nghiên cứu so sánh đơn trung tâm https://news.medxy.ai/short-term-outcomes-of-polydioxanone-synthetic-mesh-in-two-stage-breast-reconstruction-insights-from-a-single-center-comparative-study/Medxy AIen2026-10-02T07:20:12-07:00Short-Term Outcomes of Polydioxanone Synthetic Mesh in Two-Stage Breast Reconstruction: Insights from a Single-Center Comparative Study https://news.medxy.ai/zh/five-factor-weakness-index/Medxy AIzh2026-10-02T07:19:34-07:00五因素改良衰弱指数能否预测乳房缩小成形术后伤口愈合并发症？高龄或许更关键 https://news.medxy.ai/ja/breast-reduction-healing/Medxy AIja2026-10-02T07:19:11-07:00乳房縮小術後の創傷治癒合併症は予測できるか――5因子修正版フレイル指標の実力を検証 https://news.medxy.ai/vi/79748-2/Medxy AIvi2026-10-02T07:18:47-07:00Liệu có thể dự đoán các biến chứng lành vết thương sau phẫu thuật thu nhỏ vú? https://news.medxy.ai/assessing-the-predictive-value-of-the-5-factor-modified-frailty-index-for-wound-healing-complications-in-reduction-mammoplasty/Medxy AIen2026-10-02T07:18:25-07:00Assessing the Predictive Value of the 5-Factor Modified Frailty Index for Wound-Healing Complications in Reduction Mammoplasty https://news.medxy.ai/zh/adm-reconstruction-timing/Medxy AIzh2026-10-02T07:17:44-07:00前胸壁两期乳房重建中ADM植入时机如何优化：在包膜挛缩与并发症之间寻找平衡 https://news.medxy.ai/ja/adm-timing-optimization/Medxy AIja2026-10-02T07:17:25-07:00前胸壁2段階乳房再建におけるADM留置時期の最適化：被膜拘縮と合併症の両立 https://news.medxy.ai/vi/optimal-adm-timing/Medxy AIvi2026-10-02T07:17:05-07:00Tối ưu thời điểm đặt Acellular Dermal Matrix trong tái tạo vú trước cơ hai thì: Cân bằng giữa co thắt bao xơ và biến chứng https://news.medxy.ai/optimizing-acellular-dermal-matrix-timing-in-2-stage-prepectoral-breast-reconstruction-balancing-capsular-contracture-and-complications/Medxy AIen2026-10-02T07:16:43-07:00Optimizing Acellular Dermal Matrix Timing in 2-Stage Prepectoral Breast Reconstruction: Balancing Capsular Contracture and Complications https://news.medxy.ai/zh/optimize-dermal-matrix-size/Medxy AIzh2026-10-02T07:16:03-07:00优化无细胞真皮基质尺寸：降低胸肌前乳房重建包膜挛缩风险 https://news.medxy.ai/ja/adm-size-optimization/Medxy AIja2026-10-02T07:15:42-07:00前胸筋下乳房再建における被膜拘縮を抑えるADMサイズの最適化 https://news.medxy.ai/vi/optimize-dermal-matrix/Medxy AIvi2026-10-02T07:15:18-07:00Tối ưu hóa kích thước acellular dermal matrix để giảm co thắt bao xơ trong tái tạo vú trước cơ ngực https://news.medxy.ai/optimizing-acellular-dermal-matrix-size-to-minimize-capsular-contracture-in-prepectoral-breast-reconstruction/Medxy AIen2026-10-02T07:14:57-07:00Optimizing Acellular Dermal Matrix Size to Minimize Capsular Contracture in Prepectoral Breast Reconstruction https://news.medxy.ai/zh/migraine-surgery-timing/Medxy AIzh2026-10-02T07:14:17-07:00偏头痛触发点手术越早做，术后头痛改善越明显：来自台湾队列研究的启示 https://news.medxy.ai/ja/migraine-surgery-timing-2/Medxy AIja2026-10-02T07:13:55-07:00片頭痛手術は早いほど良い？ 台湾コホート研究が示す術後頭痛改善の鍵 https://news.medxy.ai/vi/79731-2/Medxy AIvi2026-10-02T07:13:34-07:00Phẫu thuật điều trị đau nửa đầu: Càng sớm càng tốt? Nghiên cứu đoàn hệ tại Đài Loan chỉ ra chìa khóa giúp cải thiện tình trạng đau đầu sau phẫu thuật https://news.medxy.ai/earlier-intervention-with-migraine-trigger-site-surgery-linked-to-improved-postoperative-headache-outcomes-insights-from-a-taiwanese-cohort-study/Medxy AIen2026-10-02T07:13:14-07:00Earlier Intervention with Migraine Trigger-Site Surgery Linked to Improved Postoperative Headache Outcomes: Insights from a Taiwanese Cohort Study